Unggahan by Jagdish Chander

Swipe ▶️

Genotoxic Impurities

Off Exclusivity Drugs

367192716 How to Market Orphan Drugs PDF

2016_CMCLat_SanchezJulio

29

FINALPUBLICNOTICE26_5_2016

Bulgaria 1

anx_54656_en

11 Estudios Pre y Clinicos

10 PRODUCTO TERMINADO.pdf

6 GMP

Clinical Trials

Interchange Ability

Interchangeability for Narrow Therapeutic Range

Installation and Operation of Pharmacovigilance

Latin American Countries Regulatory Requirements 30092011

GMP Inpsection Checklist

List of High Risk Drugs

Dossier Structures

10 Producto Terminado

ph_0000033377

Watanabe 02

Reference for FDC

ECAM2011-580752.pdf

DE_H_3677_001_PAR.pdf

ECAM2011-580752

DE_H_3677_001_PAR

1628

2

1

21005 Solaraze Pharmr P2

21005 Solaraze Pharmr P1

21005_Solaraze_microbr

21005 Solaraze Medr P1

409-1465-1-PB

409-1465-1-PB.pdf

022122_ClinPharmR

2012 Drug Information Andreas

CMDh_BPG_Compilation_of_the_Dossier_2008_03_Rev0.pdf

Pharmaceuticals 03 01892

KMAG 8 WEMU Guidelines

h 111016

h 102870

DSG PK

DK_H_2310_001_PAR

DE_H_3937_001_PAR

CZ_H_0673_002_PAR

con475306.pdf